FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

374137009: Product containing precisely estropipate 1.25 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501164015 Estropipate 1.25 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678703018 Product containing precisely estropipate 1.25 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Estropipate 1.25 mg oral tablet Is a Estrogen receptor agonist-containing product false Inferred relationship Some
Estropipate 1.25 mg oral tablet Is a Estropipate false Inferred relationship Some
Estropipate 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Hormone false Inferred relationship Some
Estropipate 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. estrogeno false Inferred relationship Some
Estropipate 1.25 mg oral tablet Is a Product containing piperazine estrone sulfate false Inferred relationship Some
Estropipate 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Estropipate false Inferred relationship Some
Estropipate 1.25 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
Estropipate 1.25 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Estropipate 1.25 mg oral tablet Is a Product containing estropipate in oral dosage form false Inferred relationship Some
Estropipate 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Estropipate false Inferred relationship Some 1
Estropipate 1.25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Estropipate true Inferred relationship Some 1
Estropipate 1.25 mg oral tablet Has presentation strength numerator value 1.25 false Inferred relationship Some 1
Estropipate 1.25 mg oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 1
Estropipate 1.25 mg oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Estropipate 1.25 mg oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Estropipate 1.25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Estropipate true Inferred relationship Some 1
Estropipate 1.25 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Estropipate 1.25 mg oral tablet Count of base of active ingredient un false Inferred relationship Some
Estropipate 1.25 mg oral tablet Is a Product containing only estrone in oral dose form (medicinal product form) false Inferred relationship Some
Estropipate 1.25 mg oral tablet Is a Estropipate only product in oral dose form true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start